KEGG   DRUG: Ingitamig
Entry
D12913                      Drug                                   
Name
Ingitamig (USAN)
Formula
C7543H11634N2024O2376S52
Exact mass
170249.7230
Mol weight
170354.70
Sequence
(Heavy chain)
EVQLLESGGG LVQPGGSLRL SCAASGFTFS DNAMGWVRQA PGKGLEWVSA ISGPGSSTYY
ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKVL GWFDYWGQGT LVTVSSASTK
GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF
LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPRVYTL PPCRDELTKN
QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLVSD GSFTLYSKLT VDKSRWQQGN
VFSCSVMHEA LHNHYTQKSL SLSPGSGSGG GGSDIQMTQS PSSVSASVGD RVTITCRASQ
GISSWLAWYQ QKPGKAPKLL IYAASSLQSG VPSRFSGSGS GTDFTLTISS LQPEDFATYY
CQQGVSFPRT FGCGTKVEIK GGGGSGGGGS GGGGSGGGGS EVQLVESGGG LVKPGGSLRL
SCAASGFTFS SYSMNWVRQA PGKCLEWVSS ISSSSSYIYY ADSVKGRFTI SRDNAKNSLY
LQMNSLRAED TAVYYCARGA PMGAAAGWFD PWGQGTLVTV SS
(heavy chain)
EVQLLESGGG LVQPGGSLRL SCAASGFTFS DNAMGWVRQA PGKGLEWVSA ISGPGSSTYY
ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKVL GWFDYWGQGT LVTVSSASTK
GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF
LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVCTL PPSRDELTEN
QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSWLT VDKSRWQQGN
VFSCSVMHEA LHNHYTQKSL SLSPG
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRASQSVS DEYLSWYQQK PGQAPRLLIH SASTRATGIP
DRFSGSGSGT DFTLAISRLE PEDFAVYYCQ QYGYPPDFTF GQGTKVEIKR TVAAPSVFIF
PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST
LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC
(Disulfide birde: H22-H96, H143-H199, H219-L216, H225-h225, H228-h228, H260-H320, H353-h348, H366-H424, H476-H541, H553-H624, H602-H676, h22-h96, h143-h199, h219-L'216, h260-h320, h366-h424, L23-L89, L136-L196, L'23-L'89, L'136-L'196)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Bispecific antibody
Comment
Treatment of relapsed or refractory multiple myeloma
Target
TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
KLRK1 (CD314, NKG2D) [HSA:22914] [KO:K06728]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04650  Natural killer cell mediated cytotoxicity
hsa04672  Intestinal immune network for IgA production
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF17 (BCMA, CD269)
     D12913  Ingitamig (USAN)
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    KLRK1 (CD314, NKG2D)
     D12913  Ingitamig (USAN)
Other DBs
CAS: 2839572-09-5
PubChem: 497621326
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system